Growth Metrics

Travere Therapeutics (TVTX) Free Cash Flow (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -166.52%
Dec 31, 2025 328.00%
Sep 30, 2025 184.51%
Jun 30, 2025 111.81%
Mar 31, 2025 -49.26%
Dec 31, 2024 33.50%
Sep 30, 2024 -5.14%
Jun 30, 2024 66.00%
Mar 31, 2024 -84.64%
Dec 31, 2023 41.76%
Sep 30, 2023 -113.61%
Jun 30, 2023 47.86%
Mar 31, 2023 -29.38%
Dec 31, 2022 16.62%
Sep 30, 2022 -149.92%
Jun 30, 2022 33.59%
Mar 31, 2022 37.33%
Dec 31, 2021 -378.98%
Sep 30, 2021 396.07%
Jun 30, 2021 120.64%
Mar 31, 2021 -141.12%
Dec 31, 2020 -396.83%
Sep 30, 2020 163.98%
Jun 30, 2020 76.97%
Mar 31, 2020 -567.19%
Dec 31, 2019 69.41%
Sep 30, 2019 24.72%
Jun 30, 2019 6.83%
Mar 31, 2019 -622.73%
Dec 31, 2018 29.49%
Sep 30, 2018 -21.16%
Jun 30, 2018 77.51%
Mar 31, 2018 -4,759.54%
Dec 31, 2017 -105.23%
Sep 30, 2017 10.84%
Jun 30, 2017 223.63%
Mar 31, 2017 56.95%
Dec 31, 2016 -314.72%
Sep 30, 2016 15.09%
Jun 30, 2016 211.11%
Mar 31, 2016 -1.47%
Dec 31, 2015 -582.81%
Sep 30, 2015 -90.85%
Jun 30, 2015 221.08%
Mar 31, 2015 27.87%
Dec 31, 2014 41.39%
Sep 30, 2014 -33.74%
Jun 30, 2014 -17.40%
Mar 31, 2014 -17.44%